Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEVONEDISTAT vs PEXIDARTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PEVONEDISTAT vs PEXIDARTINIB: Safety Overview

Metric PEVONEDISTAT PEXIDARTINIB
Total FAERS Reports 529 970
Deaths Reported 202 17
Death Rate 38.2% 1.8%
Hospitalizations 426 91
Average Patient Age 71.5 yrs 44.9 yrs
% Female Patients 40.4% 63.4%
FDA Approval Date N/A Aug 2, 2019
Manufacturer N/A Daiichi Sankyo Inc.
Route N/A ORAL
Marketing Status N/A Discontinued